|
|
|
Insider
Information: |
Schenkein David P |
Relationship: |
Director |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
168,823 |
|
Indirect Shares
|
417,826 |
|
|
Direct
Value |
$4,894,341 |
|
|
Indirect Value
|
$13,407,961 |
|
|
Total
Shares |
586,649 |
|
|
Total
Value |
$18,302,302 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
3
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
3.0
|
Percentage
Gain/Loss : |
0.0%
|
13.1%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Agios Pharmaceuticals Inc |
AGIO |
Director |
2024-02-27 |
122,854 |
2024-02-27 |
349,854 |
Premium* |
|
Foundation Medicine, Inc. |
FMI |
Director |
2016-06-16 |
23,326 |
2016-06-16 |
10,508 |
Premium* |
|
Bluebird Bio, Inc. |
BLUE |
|
2020-06-18 |
6,832 |
2014-12-19 |
0 |
Premium* |
|
Denali Therapeutics Inc. |
DNLI |
Director |
2023-06-01 |
15,529 |
2023-06-01 |
57,464 |
Premium* |
|
Regeneron Pharmaceuticals Inc |
REGN |
Director |
2024-01-02 |
282 |
2023-09-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
153 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive OfficerOfficer |
|
2013-07-23 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
374,544 |
|
- |
|
FMI |
Foundation Medicine, Inc. |
Director |
|
2013-09-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
31,250 |
|
- |
|
FMI |
Foundation Medicine, Inc. |
Director |
|
2013-09-30 |
4 |
A |
$0.00 |
$0 |
I/I |
62,500 |
31,250 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2014-03-10 |
4 |
OE |
$0.30 |
$16,335 |
I/I |
54,000 |
241,272 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2014-03-25 |
4 |
OE |
$0.30 |
$7,563 |
I/I |
25,000 |
266,272 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2014-07-01 |
4 |
AS |
$46.52 |
$604,760 |
I/I |
(13,000) |
180,772 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2014-08-01 |
4 |
AS |
$39.17 |
$331,770 |
I/I |
(8,470) |
176,537 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2014-08-11 |
4 |
AS |
$40.17 |
$181,970 |
I/I |
(4,530) |
174,272 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2014-09-02 |
4 |
AS |
$46.30 |
$601,900 |
I/I |
(13,000) |
167,772 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2014-09-02 |
4 |
OE |
$0.30 |
$1,966 |
I/I |
6,500 |
259,772 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2014-09-26 |
4 |
OE |
$0.30 |
$9,075 |
I/I |
30,000 |
283,272 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2014-09-26 |
4 |
AS |
$62.68 |
$3,760,800 |
I/I |
(60,000) |
137,772 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2014-10-01 |
4 |
OE |
$0.30 |
$756 |
I/I |
2,500 |
255,772 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2014-10-01 |
4 |
AS |
$60.07 |
$780,910 |
I/I |
(13,000) |
131,272 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2014-11-03 |
4 |
AS |
$81.71 |
$1,062,230 |
I/I |
(13,000) |
124,772 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2014-12-01 |
4 |
AS |
$97.03 |
$1,261,390 |
I/I |
(13,000) |
118,272 |
0 |
- |
|
BLUE |
Bluebird Bio, Inc. |
Director |
|
2014-12-19 |
4 |
B |
$85.00 |
$99,960 |
D/D |
1,176 |
1,176 |
2.39 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2015-01-02 |
4 |
AS |
$110.08 |
$1,431,040 |
I/I |
(13,000) |
111,772 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2015-02-02 |
4 |
AS |
$114.31 |
$1,188,824 |
I/I |
(10,400) |
107,872 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2015-02-11 |
4 |
AS |
$120.14 |
$94,550 |
I/I |
(787) |
107,085 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2015-02-13 |
4 |
AS |
$120.31 |
$82,292 |
I/I |
(684) |
106,401 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2015-02-27 |
4 |
OE |
$0.30 |
$7,563 |
I/I |
25,000 |
248,272 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2015-03-02 |
4 |
AS |
$107.05 |
$834,990 |
I/I |
(7,800) |
105,101 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2015-03-05 |
4 |
AS |
$110.16 |
$286,416 |
I/I |
(2,600) |
102,501 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2015-03-12 |
4 |
GD |
$0.00 |
$0 |
I/I |
190 |
94,511 |
0 |
- |
|
153 Records found
|
|
Page 1 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|